Search
Lexaria Bioscience Corp
LEXXAdd to Watchlist
3.080USD
+0.090+3.01%
Close 10-22 16:00（ET）
6.50MMarket Cap
LossP/E TTM
Lexaria Bioscience Corp (LEXX) Stock Price Target & Forecast
Target Price
52.500USD+1735.66%
LEXX Analyst Recommendation Trends
In the current month, LEXX has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. LEXX average Analyst price target in the last month is 52.500.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
LEXX Analyst Rating for Peer Comparison
Updated: Oct 20, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Biogen Inc
BIIB
9
17
11
1
0
38
Amgen Inc
AMGN
4
9
19
3
1
36
AbbVie Inc
ABBV
8
19
6
0
0
33
Vertex Pharmaceuticals Inc
VRTX
10
17
5
0
1
33
Eli Lilly and Co
LLY
10
19
3
1
0
33
Alnylam Pharmaceuticals Inc
ALNY
7
17
8
0
0
32
Gilead Sciences Inc
GILD
7
18
6
0
0
31
Merck & Co Inc
MRK
7
16
8
0
0
31
Neurocrine Biosciences Inc
NBIX
13
14
4
0
0
31
Regeneron Pharmaceuticals Inc
REGN
7
15
9
0
0
31
Financial Forecasting
Based on analysts' estimates, LEXX EPS is projected to reach -0.900 in FY2026Q4, following reported EPS of -1.204 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-1.95
-1.43
-1.27
-0.90
Actual
-1.12
-0.06
-1.20
--
Surprise
+42.60%
+95.84%
+5.56%
--
FAQs
What is Lexaria Bioscience Corp's price target?
Analysts forecast that Lexaria Bioscience Corp's price target is USD 52.50, with the highest forecast at USD 82.50 and the lowest forecast at USD 22.50.
How have Lexaria Bioscience CorpLEXX's recent earnings per share performed?
The market expectation was USD -1.20, while Lexaria Bioscience CorpLEXX's earnings per share (EPS) for the previous quarter was USD -0.06. EPS for the next quarter is expected at USD -0.90.